Literature DB >> 21294129

Identification of amino acid residues responsible for the release of free drug from an antibody-drug conjugate utilizing lysine-succinimidyl ester chemistry.

Hung-Wei Chih1, Benson Gikanga, Yi Yang, Boyan Zhang.   

Abstract

Unexpected release of free drug was observed during the stability testing of an antibody-drug conjugate (ADC). The ADC was designed to use lysine-succinimidyl ester chemistry to conjugate small molecule cytotoxic drugs to the antibody. To elucidate the mechanism of the release of free drug, a succinimidyl ester analog, 7-hydroxy-4-methyl-3-coumarinylacetic acid N-succinimidyl ester, and a series of peptides were used to probe the potential side reaction of succinimidyl ester with other amino acid residues. Cysteine and tyrosine residues were found to be reactive to succinimidyl ester, and the bonds formed through these reactions were found to be labile. Combining the fluorescent property of the succinimidyl ester analog and mass spectroscopy analysis, specific cysteine and tyrosine residues of the antibody were found to be reactive to succinimidyl ester and the bonds formed through this reaction were susceptible to hydrolysis.
Copyright © 2011 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294129     DOI: 10.1002/jps.22485

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  Challenges and new frontiers in analytical characterization of antibody-drug conjugates.

Authors:  Anil Wagh; Hangtian Song; Ming Zeng; Li Tao; Tapan K Das
Journal:  MAbs       Date:  2018-01-05       Impact factor: 5.857

2.  A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.

Authors:  Chunze Li; Priya Agarwal; Ekaterina Gibiansky; Jin Yan Jin; Susan Dent; Anthony Gonçalves; Ihsan Nijem; Alexander Strasak; Marie-Laurence Harle-Yge; Nataliya Chernyukhin; Pat LoRusso; Sandhya Girish
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

3.  Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol- maleimide chemistry.

Authors:  Jianxin Guo; Sandeep Kumar; Amarnauth Prashad; Jason Starkey; Satish K Singh
Journal:  Pharm Res       Date:  2014-01-24       Impact factor: 4.200

4.  Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates.

Authors:  Nicholas J Boylan; Wen Zhou; Robert J Proos; Thomas J Tolbert; Janet L Wolfe; Jennifer S Laurence
Journal:  Bioconjug Chem       Date:  2013-05-31       Impact factor: 4.774

Review 5.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.